[1] [1] WANG H L, HU Y, TAN C, et al. Differential diagnosis of breast mucinous carcinoma with an oval shape from fibroadenoma based on ultrasonographic features[J]. BMC Womens Health, 2024, 24(1): 87.

[2] [2] BARKLEY C R, LIGIBEL J A, WONG J S, et al. Mucinous breast carcinoma: a large contemporary series[J]. Am J Surg, 2008, 196(4): 549-551.

[3] [3] BAE S Y, CHOI M Y, CHO D H, et al. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis[J]. J Breast Cancer, 2011, 14(4): 308-313.

[4] [4] BOARD W C O T E. Breast tumors[M]. 5th ed. Lyon: IARC Press, 2019.

[5] [5] FENTIMAN I S, MILLIS R R, SMITH P, et al. Mucoid breast carcinomas: histology and prognosis[J]. Br J Cancer, 1997, 75(7): 1061-1065.

[6] [6] JONEJA U, PALAZZO J. The spectrum of mucinous lesions of the breast[J]. Arch Pathol Lab Med, 2023, 147(1): 19-29.

[9] [9] TAN P H. Fibroepithelial lesions revisited: implications for diagnosis and management[J]. Mod Pathol, 2021, 34(Suppl 1): 15-37.

[10] [10] YAN C X, LUO Z Y, LIN Z M, et al. Shear wave elastographyassisted ultrasound breast image analysis and identification of abnormal data[J]. J Healthc Eng, 2022, 2022: 5499354.

[11] [11] LI C Y, GONG H Y, LING L J, et al. Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules[J]. J Biomed Res, 2018, 32(3): 198-207.

[12] [12] GUO W J, LI F, JIA C, et al. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging[J]. Br J Radiol, 2022, 95(1136): 20220025.

[13] [13] LI S Y, NIU R L, WANG B, et al. Determining whether the diagnostic value of B-ultrasound combined with contrastenhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test[J]. Gland Surg, 2023, 12(2): 282-296.

[14] [14] CHEN X Y, YU H R, WEI N, et al. Diagnostic performance of contrast-enhanced ultrasound combined with shear wave elastography in differentiating benign from malignant breast lesions: a systematic review and meta-analysis[J]. Gland Surg, 2023, 12(11): 1610-1623.

[15] [15] HE H L, WU X J, JIANG M J, et al. Diagnostic accuracy of contrast-enhanced ultrasound synchronized with shear wave elastography in the differential diagnosis of benign and malignant breast lesions: a diagnostic test[J]. Gland Surg, 2023, 12(1): 54-66.

[16] [16] LARSEN C M, GARCIA ARANGO M, DASARI H, et al. Association of anthracycline with heart failure in patients treated for breast cancer or lymphoma, 1985-2010[J]. JAMA Netw Open, 2023, 6(2): e2254669.

[17] [17] Adler D D, Carson P L, Rubin J M, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings[J]. Ultrasound Med Biol, 1990, 16(6): 553-559.

[18] [18] TOZAKI M, FUKUMA E. Pattern classification of ShearWave™ Elastography images for differential diagnosis between benign and malignant solid breast masses[J]. Acta Radiol, 2011, 52(10): 1069-1075.

[19] [19] MARRAZZO E, FRUSONE F, MILANA F, et al. Mucinous breast cancer: a narrative review of the literature and a retrospective tertiary single-centre analysis[J]. Breast, 2020, 49: 87-92.

[20] [20] BUDZIK M P, FUDALEJ M M, BADOWSKA-KOZAKIEWICZ A M. Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type[J]. Sci Rep, 2021, 11(1): 5770.

[21] [21] PINTICAN R, DUMA M, CHIOREAN A, et al. Mucinous versus medullary breast carcinoma: mammography, ultrasound, and MRI findings[J]. Clin Radiol, 2020, 75(7): 483-496.

[22] [22] CHAUDHRY A R, EL KHOURY M, GOTRA A, et al. Imaging features of pure and mixed forms of mucinous breast carcinoma with histopathological correlation[J]. Br J Radiol, 2019, 92(1095): 20180810.

[23] [23] KAOKU S, KONISHI E, FUJIMOTO Y, et al. Sonographic and pathologic image analysis of pure mucinous carcinoma of the breast[J]. Ultrasound Med Biol, 2013, 39(7): 1158-1167.

[24] [24] CHOPRA S, EVANS A J, PINDER S E, et al. Pure mucinous breast cancer-mammographic and ultrasound findings[J]. Clin Radiol, 1996, 51(6): 421-424.

[25] [25] CUI X W, LI K N, YI A J, et al. Ultrasound elastography[J]. Endosc Ultrasound, 2022, 11(4): 252-274.

[26] [26] ACHICANOY PUCHANA D M, LASSO ANDRADE F A, ACHICANOY PUCHANA D F, et al. Mucinous carcinoma of the breast: diagnosis and management of an unusually young patient[J]. Radiol Case Rep, 2022, 17(5): 1445-1449.

[27] [27] IGARASHI T, ASHIDA H, MORIKAWA K, et al. Use of BIRADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma[J]. Eur J Radiol, 2016, 85(6): 1092-1098.

[28] [28] LI X, CHAI W M, SUN K, et al. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI[J]. Magn Reson Imaging, 2024, 106: 8-17.

[29] [29] YANG W S, LI Y, GAO Y. On ultrasonographic features of mucinous carcinoma with micropapillary pattern[J]. Breast Cancer (Dove Med Press), 2023, 15: 473-483.

[30] [30] LI Y J, WEN G, WANG Y, et al. Perfusion heterogeneity in breast tumors for assessment of angiogenesis[J]. J Ultrasound Med, 2013, 32(7): 1145-1155.